United Arab Emirates - Re-Export of Heparin for Therapeutic Use
Since 2014, United Arab Emirates Re-Export of Heparin for Therapeutic Use increased 23.1% year on year. In 2019, the country was number 7 among other countries in Re-Export of Heparin for Therapeutic Use with $46,048.8. United Arab Emirates is overtaken by New Zealand, which was number 6 at $90,204.13 and is followed by Cyprus with $10,187.59. United States lead the ranking with $4,598,060.57 in 2019, a fall of 5.2% versus 2018. Canada, Barbados and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +141.8% per year, while United States was the worst growing country at -29.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 46,048.80 |
| 2018 | 53,967.61 |
| 2017 | 10,161.47 |
| 2016 | 17,427.88 |
| 2015 | 61,890.74 |
Download all data from 2007 to 2019
How does United Arab Emirates rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data | |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data | |
| 6 |
#6
New Zealand
|
90,204.13 | 2019 | -3.7 % | +141.8 % | View data | |
| 7 |
#7
United Arab Emirates
|
46,048.80 | 2019 | -14.7 % | +23.1 % | View data | |
| 8 |
#8
Cyprus
|
10,187.59 | 2018 | NA | NA | View data | |